Condition: Colorectal Cancer · Resectable Colorectal Carcinoma · Sponsor: Gruppo Oncologico del Nord-Ovest
This is a window-of-opportunity umbrella platform trial enrolling non-metastatic resectable colorectal patients selected for the presence of a specific targetable molecular alteration. The study aims to test the activity of specific targeted agents/combinations given as a short-course pre-operative strategy, matched with the specific alteration detected, followed by standard of care surgery.
This description comes directly from the study's public registry record.
Filippo Pietrantonio, MD · +39 0223903807 · filippo.pietrantonio@istitutotumori.mi.it
Federica Palermo · +39 0223903835 · unicornstudy@istitutotumori.mi.it
Always discuss trial participation with your own doctor first.
| Fondazione IRCCS Istituto Nazionale dei Tumori di Milano | Milan, Lombardia/MI, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05845450